PD39-09 STATIN DRUG USE AND RISK OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA (BPH): RESULTS FROM THE PROSTATE CANCER PREVENTION TRIAL

Drug Use ◽

Cancer Prevention ◽

Prostatic Hyperplasia ◽

Prevention Trial ◽

Prostate Cancer Prevention Trial ◽

Statin Drug

Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial

The Prostate ◽

10.1002/pros.20974 ◽

2009 ◽

Vol 69 (12) ◽

pp. 1303-1311 ◽

Cited By ~ 19

Author(s):

Jeannette M. Schenk ◽

Alan R. Kristal ◽

Marian L. Neuhouser ◽

Catherine M. Tangen ◽

Emily White ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Prevention ◽

Prostatic Hyperplasia ◽

Prevention Trial ◽

Serum Adiponectin ◽

C Peptide ◽

Association of Symptomatic Benign Prostatic Hyperplasia and Prostate Cancer: Results from the Prostate Cancer Prevention Trial

10.1093/aje/kwq493 ◽

2011 ◽

Vol 173 (12) ◽

pp. 1419-1428 ◽

Cited By ~ 35

Author(s):

J. M. Schenk ◽

A. R. Kristal ◽

K. B. Arnold ◽

C. M. Tangen ◽

M. L. Neuhouser ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Prevention ◽

Prostatic Hyperplasia ◽

Prevention Trial ◽

Biomarkers of Systemic Inflammation and Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial

10.1093/aje/kwp406 ◽

2010 ◽

Vol 171 (5) ◽

pp. 571-582 ◽

Cited By ~ 63

Author(s):

J. M. Schenk ◽

A. R. Kristal ◽

M. L. Neuhouser ◽

C. M. Tangen ◽

E. White ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Prevention ◽

Systemic Inflammation ◽

Prostatic Hyperplasia ◽

Prevention Trial ◽

Dietary Patterns, Supplement Use, and the Risk of Symptomatic Benign Prostatic Hyperplasia: Results from the Prostate Cancer Prevention Trial

10.1093/aje/kwm389 ◽

2008 ◽

Vol 167 (8) ◽

pp. 925-934 ◽

Cited By ~ 116

Author(s):

A. R. Kristal ◽

K. B. Arnold ◽

J. M. Schenk ◽

M. L. Neuhouser ◽

P. Goodman ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Prevention ◽

Dietary Patterns ◽

Prostatic Hyperplasia ◽

Prevention Trial ◽

Supplement Use ◽

Indications For and Use of Nonsteroidal Antiinflammatory Drugs and the Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial

10.1093/aje/kwr524 ◽

2012 ◽

Vol 176 (2) ◽

pp. 156-163 ◽

Cited By ~ 19

Author(s):

J. M. Schenk ◽

G. S. Calip ◽

C. M. Tangen ◽

P. Goodman ◽

J. K. Parsons ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Prevention ◽

Nonsteroidal Antiinflammatory Drugs ◽

Prostatic Hyperplasia ◽

Prevention Trial ◽

Antiinflammatory Drugs ◽

Re: "Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial"

10.1093/aje/kwr450 ◽

2011 ◽

Vol 174 (12) ◽

pp. 1425-1425 ◽

Cited By ~ 1

Keyword(s):

Prostate Cancer ◽

Cancer Prevention ◽

Prostatic Hyperplasia ◽

Prevention Trial ◽

Serum Steroid and Sex Hormone-Binding Globulin Concentrations and the Risk of Incident Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial

10.1093/aje/kwn272 ◽

2008 ◽

Vol 168 (12) ◽

pp. 1416-1424 ◽

Cited By ~ 42

Author(s):

A. R. Kristal ◽

J. M. Schenk ◽

Y. Song ◽

K. B. Arnold ◽

M. L. Neuhouser ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Prevention ◽

Prostatic Hyperplasia ◽

Sex Hormone ◽

Prevention Trial ◽

Sex Hormone Binding Globulin ◽

Hormone Binding ◽

Race/Ethnicity, Obesity, Health Related Behaviors and the Risk of Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial

The Journal of Urology ◽

10.1016/j.juro.2006.11.065 ◽

2007 ◽

Vol 177 (4) ◽

pp. 1395-1400 ◽

Cited By ~ 127

Author(s):

Alan R. Kristal ◽

Kathryn B. Arnold ◽

Jeannette M. Schenk ◽

Marian L. Neuhouser ◽

Noel Weiss ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Prevention ◽

Prostatic Hyperplasia ◽

Prevention Trial ◽

Health Related Behaviors ◽

Health Related ◽

Race Ethnicity

Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial

The Prostate ◽

10.1002/pros.21092 ◽

2009 ◽

Vol 70 (6) ◽

pp. 584-590 ◽

Cited By ~ 5

Author(s):

Alan R. Kristal ◽

Douglas K. Price ◽

Cathee Till ◽

Jeannette M. Schenk ◽

Marian L. Neuhouser ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Cancer Prevention ◽

Prostatic Hyperplasia ◽

Repeat Length ◽

Cag Repeat ◽

Prevention Trial ◽

Prostate Cancer Prevention

Faculty Opinions recommendation of Long-term survival of participants in the prostate cancer prevention trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718075959.793484159 ◽

2013 ◽

Author(s):

Peter Albertsen

Keyword(s):

Prostate Cancer ◽

Cancer Prevention ◽

Prevention Trial ◽

Term Survival ◽

Long Term Survival ◽